Cite
HARVARD Citation
Yoo, D. et al. (n.d.). FRI0128 A NOVEL FORMULATION OF CT-P13 (INFLIXIMAB BIOSIMILAR) FOR SUBCUTANEOUS ADMINISTRATION: 1-YEAR RESULTS FROM A PART 1 OF PHASE I/III RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. Annals of the rheumatic diseases. p. 733. [Online].